Tradition Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-426
| Closed | -$207K | – | 474 |
|
2025
Q1 | $207K | Buy |
+426
| New | +$207K | 0.02% | 404 |
|
2024
Q1 | – | Sell |
-410
| Closed | -$167K | – | 1174 |
|
2023
Q4 | $167K | Buy |
410
+10
| +3% | +$4.07K | 0.02% | 350 |
|
2023
Q3 | $139K | Buy |
400
+1
| +0.3% | +$348 | 0.02% | 366 |
|
2023
Q2 | $140K | Buy |
399
+1
| +0.3% | +$351 | 0.02% | 378 |
|
2023
Q1 | $125K | Buy |
398
+9
| +2% | +$2.83K | 0.02% | 381 |
|
2022
Q4 | $112K | Buy |
389
+2
| +0.5% | +$576 | 0.02% | 351 |
|
2022
Q3 | $112K | Buy |
387
+359
| +1,282% | +$104K | 0.02% | 343 |
|
2022
Q2 | $8K | Hold |
28
| – | – | ﹤0.01% | 883 |
|
2022
Q1 | $7K | Hold |
28
| – | – | ﹤0.01% | 988 |
|
2021
Q4 | $6K | Hold |
28
| – | – | ﹤0.01% | 1031 |
|
2021
Q3 | $5K | Sell |
28
-100
| -78% | -$17.9K | ﹤0.01% | 1046 |
|
2021
Q2 | $26K | Hold |
128
| – | – | ﹤0.01% | 694 |
|
2021
Q1 | $28K | Hold |
128
| – | – | ﹤0.01% | 564 |
|
2020
Q4 | $30K | Buy |
+128
| New | +$30K | 0.01% | 511 |
|